Natus set to purchase brain monitoring technology
This article was originally published in Clinica
Diagnostics firm Natus Medical is set to boost its newborn brain injury products portfolio with the purchase of New Zealand-based bedside brain monitoring company BrainZ Instruments. The deal, expected to close in early November 2008, will see Natus acquire all the trading assets of Auckland-based BrainZ, including the BRM2 and BRM3 monitoring devices for newborns and the RecogniZe detection system for NZ$1.3m ($800,000). Natus will also undertake the various distribution agreements for the technology it has acquired. The San Carlos, California-based firm expects this acquisition to be accretive to earnings in the first full quarter following the deal. Natus’ existing newborn brain injury products include the Olympic CFM 6000 bedside cerebral function monitor.